Press Releases

November 14, 2022
Sionna Therapeutics Announces Appointment of Vanya Sagar as Chief People Officer
Read more
November 3, 2022
Sionna Therapeutics Presents Preclinical Data Demonstrating Restoration of ΔF508-CFTR by Stabilizing NBD1 with SION-638 in Cystic Fibrosis
Read more
October 4, 2022
Sionna Therapeutics to Present at the North American Cystic Fibrosis Conference
Read more
August 1, 2022
Sionna Therapeutics Announces Formation of Scientific Advisory Board
Read more
June 6, 2022
Sionna Therapeutics Announces Appointment of Paul Clancy to Board of Directors
Read more
April 19, 2022
Sionna Therapeutics Launches with $111 Million Series B Financing to Advance Pipeline of Novel Small Molecules with the Potential to Fully Restore CFTR Function in Cystic Fibrosis
Read more